Cargando…
Difficulties Associated with Enzyme Replacement Therapy for Mucopolysaccharidoses
BACKGROUND: Mucopolysaccharidoses are extremely rare, progressive, often severe multisystem disorders, some of which are managed by weekly intravenous enzyme replacement therapy. This study aimed to determine the difficulties faced by the patients with mucopolysaccharidosis and their families due to...
Autores principales: | Yıldız, Yılmaz, Sivri, H. Serap |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Pediatrics Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849081/ https://www.ncbi.nlm.nih.gov/pubmed/35110060 http://dx.doi.org/10.5152/TurkArchPediatr.2021.21235 |
Ejemplares similares
-
Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses
por: Sato, Yuji, et al.
Publicado: (2020) -
Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt
por: Fateen, Ekram, et al.
Publicado: (2021) -
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
por: Parini, Rossella, et al.
Publicado: (2020) -
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzyme Replacement Therapy
por: Poswar, Fabiano de Oliveira, et al.
Publicado: (2022) -
Enzyme replacement therapy interruption in patients with Mucopolysaccharidoses: Recommendations for distinct scenarios in Latin America
por: Solano, MarthaL., et al.
Publicado: (2020)